Neurociencias
Departamento
Hospital Universitario Central de Asturias
Oviedo, EspañaPublicaciones en colaboración con investigadoras/es de Hospital Universitario Central de Asturias (95)
2024
-
Defining a standard set of health outcomes for patients with relapsing-remitting multiple sclerosis
Multiple Sclerosis and Related Disorders, Vol. 84
-
Description of clinical and genetic features of 122 patients included in the Spanish Pompe registry
Neuromuscular Disorders, Vol. 34, pp. 1-8
-
RE-START: Exploring the effectiveness of anti-calcitonin gene-related peptide resumption after discontinuation in migraine
European Journal of Neurology, Vol. 31, Núm. 4
-
Somatic CAG repeat instability in intermediate alleles of the HTT gene and its potential association with a clinical phenotype
European Journal of Human Genetics
2023
-
Changes in Principal Caregiver Mood Affects the Mood of the Parkinson's Disease Patient: The Vicious Cycle of Illness
Journal of Parkinson's disease, Vol. 13, Núm. 2, pp. 219-231
-
Cognitive impairment and dementia in young onset Parkinson’s disease
Journal of Neurology, Vol. 270, Núm. 12, pp. 5793-5812
-
Difficulties during delivery, brain ventricle enlargement and cognitive impairment in first episode psychosis
Psychological Medicine
-
Effectiveness and Safety of Teriflunomide in Relapsing–Remitting Multiple Sclerosis and Improvements in Quality of Life: Results from the Real-World TERICARE Study
Neurology and Therapy, Vol. 12, Núm. 6, pp. 2177-2193
-
Embracing Monogenic Parkinson's Disease: The MJFF Global Genetic PD Cohort
Movement Disorders, Vol. 38, Núm. 2, pp. 286-303
-
Erratum: Author Correction: Common variants in Alzheimer's disease and risk stratification by polygenic risk scores (Nature communications (2021) 12 1 (3417))
Nature communications
-
Expanding the phenotypic spectrum of TRAPPC11-related muscular dystrophy: 25 Roma individuals carrying a founder variant
Journal of medical genetics, Vol. 60, Núm. 10, pp. 965-973
-
Falls Predict Acute Hospitalization in Parkinson's Disease
Journal of Parkinson's disease, Vol. 13, Núm. 1, pp. 105-124
-
Long-term effectiveness and tolerability of galcanezumab in patients with migraine excluded from clinical trials: real world evidence of 1055 patients with 1 year follow-up from the Galca-Only registry
Journal of Headache and Pain, Vol. 24, Núm. 1
-
Prevalence and Factors Associated with Drooling in Parkinson's Disease: Results from a Longitudinal Prospective Cohort and Comparison with a Control Group
Parkinson's Disease, Vol. 2023
-
Risk of Cognitive Impairment in Patients With Parkinson’s Disease With Visual Hallucinations and Subjective Cognitive Complaints
Journal of Clinical Neurology (Korea), Vol. 19, Núm. 4, pp. 344-357
-
Sex Differences in Motor and Non-Motor Symptoms among Spanish Patients with Parkinson’s Disease
Journal of Clinical Medicine, Vol. 12, Núm. 4
-
Staging Parkinson's Disease According to the MNCD (Motor/Non-motor/Cognition/Dependency) Classification Correlates with Disease Severity and Quality of Life
Journal of Parkinson's disease, Vol. 13, Núm. 3, pp. 379-402
-
Suicidal ideation among people with Parkinson's disease and comparison with a control group
International journal of geriatric psychiatry, Vol. 38, Núm. 5, pp. e5919
2022
-
Consensus statement on the use of alemtuzumab in daily clinical practice in Spain
Neurologia, Vol. 37, Núm. 8, pp. 615-630
-
Constipation Predicts Cognitive Decline in Parkinson's Disease: Results from the COPPADIS Cohort at 2-Year Follow-up and Comparison with a Control Group
Journal of Parkinson's Disease, Vol. 12, Núm. 1, pp. 315-331